Successful Switch to Vemurafenib Plus Cobimetinib After Dabrafenib Plus Trametinib Toxicity in BRAFV600E-Mutant Metastatic Non–Small-Cell Lung Cancer

Saved in:
Bibliographic Details
Published inClinical lung cancer Vol. 22; no. 1; pp. e54 - e56
Main Authors Chic, Nuria, Mezquita, Laura, Aldea, Mihaela, Chebib, Ralph, Caramella, Caroline, Planchard, David, Besse, Benjamin
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.01.2021
Subjects
BRAF inhibitor
Interstitial lung disease
MEK inhibitor
NSCLC
BRAF inhibitor
MEK inhibitor
NSCLC
Interstitial lung disease
Online AccessGet full text

Cover

More Information
ISSN:1525-7304
DOI:10.1016/j.cllc.2020.07.013